[1] J.B. Vieira, F.S. Braga, C.C. Lobato, C.F. Santos, J.S. Costa, J.A.H. Bittencourt, D.S. Brasil, J.O. Silva, L.I. Hage-Melim, W.J.C. Macêdo, A QSAR, Pharmacokinetic and Toxicological Study of New Artemisinin Compounds with Anticancer Activity, Molecules., 19 (2014) 10670-10697.
[2] M.H. Bohari, H.K. Srivastava, G.N. Sastry, Analogue-based approaches in anti-cancer compound modelling: the relevance of QSAR models, Org. Med. Chem. Lett., 1 (2011) 1-12.
[3] J. Yan, Y. Pang, J. Sheng, Y. Wang, J. Chen, J. Hu, L. Huang, X. Li, A novel synthetic compound exerts effective anti-tumour activity in vivo via the inhibition of tubulin polymerisation in A549 cells, Biochem. Pharmacol., 97 (2015) 51-61.
[4] G.M. Cragg, P.G. Grothaus, D.J. Newman, Impact of Natural Products on Developing New Anti-Cancer Agents†, Chem. Revi., 109 (2009) 3012-3043.
[5] W. Liao, G. Hu, Z. Guo, D. Sun, L. Zhang, Y. Bu, Y. Li, Y. Liu, P. Gong, Design and biological evaluation of novel 4-(2-fluorophenoxy) quinoline derivatives bearing an imidazolone moiety as c-Met kinase inhibitors, Bioorg. Med. Chem., 23 (2015) 4410-4422.
[6] T. Fujita, QSAR and drug design, Elsevier, 1995.
[7] J.C. Madden, M.T. Cronin, Structure-based methods for the prediction of drug metabolism, (2006).
[8] E. Pourbasheer, R. Aalizadeh, M.R. Ganjali, P. Norouzi, J. Shadmanesh, QSAR study of ACK1 inhibitors by genetic algorithm–multiple linear regression (GA–MLR), J. Saudi. Chem. Soc., 18 (2014) 681-688.
[9] W. Li, Y. Tang, Y.-L. Zheng, Z.-B. Qiu, Molecular modeling and 3D-QSAR studies of indolomorphinan derivatives as kappa opioid antagonists, Bioorg. Med. Chem., 14 (2006) 601-610.
[10] A. Habibi-Yangjeh, E. Pourbasheer, M. Danandeh-Jenagharad, Prediction of basicity constants of various pyridines in aqueous solution using a principal component-genetic algorithm-artificial neural network, Monatsh. Chem., 139 (2008) 1423-1431.
[11] A. Habibi-Yangjeh, E. Pourbasheer, M. Danandeh-Jenagharad, Application of principal component-genetic algorithm-artificial neural network for prediction acidity constant of various nitrogen-containing compounds in water, Monatsh. Chem., 140 (2009) 15-27.
[12] R.R. Hocking, A Biometrics invited paper. The analysis and selection of variables in linear regression, Biometrics., 32 (1976) 1-49.
[13] Q. Shen, Q.-Z. Lü, J.-H. Jiang, G.-L. Shen, R.-Q. Yu, Quantitative structure–activity relationships (QSAR): studies of inhibitors of tyrosine kinase, European journal of pharmaceutical sciences, 20 (2003) 63-71.
[14] E. Pourbasheer, S. Riahi, M.R. Ganjali, P. Norouzi, QSAR study on melanocortin-4 receptors by support vector machine, Eur. J. Med. Chem., 45 (2010) 1087-1093.
[15] V. Vapnik, Statistical learning theory. 1998, in, Wiley, New York, 1998.
[16] H. Khajehsharifi, M. Sadeghi, E. Pourbasheer, Spectrophotometric simultaneous determination of ceratine, creatinine, and uric acid in real samples by orthogonal signal correction–partial least squares regression, Monatsh. Chem., 140 (2009) 685-691.
[17] P. Gramatica, P. Pilutti, E. Papa, Validated QSAR prediction of OH tropospheric degradation of VOCs: splitting into training-test sets and consensus modeling, J. Chem. Inf. Comput. Sci., 44 (2004) 1794-1802.
[18] R. Todeschini, V. Consonni, A. Mauri, M. Pavan, DRAGON-Software for the calculation of molecular descriptors, Web version, 3 (2003).
[19] R. Leardi, R. Boggia, M. Terrile, Genetic algorithms as a strategy for feature selection, J. Chemom., 6 (1992) 267-281.
[20] I. MathWorks, Genetic Algorithm and Direct Search Toolbox for Use with MATLAB: User’s Guide, in, MathWorks, 2005.
[21] P. Pargolghasemi, M.S. Hoseininezhad-Namin, A. Parchehbaf Jadid, Prediction of Activities of BRAF (V600E) Inhibitors by SW-MLR and GA-MLR Methods, Curr. Comput. Aided. Drug. Des., 13 (2017) 249-261.